CARCINOMA OF URINARY BLADDER

CARCINOMA OF URINARY BLADDER


                CARCINOMA OF URINARY BLADDER

  • More common in whites, higher social- economic status.
  • 75% tumours are localised to bladder
  • 25% spread to regional nodes

  

CLASSIFICATION-

I) According to histologically-

a) Transitional cell carcinoma (90%)

b) Squamous cell carcinoma

c) Adenocarcinoma

d) Mixed

e) Undifferentiated

  

ETIOLOGY-

  1. Transitional cell carcinoma
  • Cigratte smoking (MC)
  • Chemical carcinogens- naphthylamine benzidine, aniline, acrolein, hydrocarbons (BHAAM)
  • Schistosomiasis
  • Drugs- phenacetin, chlornaphazine, cyclophosphamide, analgesic
  • Pelvic irradiation
  • Occupation- rubber, leather etc

    2. Squamous cell carcinoma

  • Schistosomiasis
  • Chronic UTI
  • Bladder diverticula

    3. Adenocarcinoma (5%)

  • Urahal remnants
  • Ectopia vesicae
  • Occurs in intestinal urinary conduits, augmentation, pouches and ureterosigmoidotomies

FEATURES-

  1. Transitional Cell carcinoma
  • MC type of bladder tumour
  • MC appears as papillary or exophytic lesions
  • Carcinoma in situ or flat urotheal carcinoma
  • Pagetoid spread
  • Sites- lateral wall (MC), trigone

     2. Squamous Cell carcinoma-

  • Arise from lateral bladder wall and dome
  • Nodular and invasive

     3. Adenocarcinoma

  • 3 types- primary vesical, urchal, metastatic
  • Primary adenocarcinoma arise along the floor
  • Adenocarcinoma arising from urachus occurs at the dome.

  

PATHOLOGY-

  • MC type grossly in Papillary
  • MC type histologically Transitional cell carcinoma

 

CLINICAL FEATURES-

  • Most tumours develop at trigone and adjacent posterolateral wall with urethral involvement
  • Tumour tend to be multifocal in bladder

 

STAGING-

  

 

INVESTIGATIONS-

  1. Cystoscopy (gold standard investigations)-
  • Cystoscopy and transurethral resection (TUR) is for diagnosis
  • Detecting cancer in symptomatic patient and assessing response to treatment
  • Most useful for early diagnosis of recurrence in TCC

     2. IVP-

  • Filling defect in bladder, dilatation of ureter

     3. Ultrasound-

  • It is useful investigation which can detect a bladder carcinoma
  • Can detect liver metastases

     4. CT scan is IOC for staging

     5. Bimanual palpation-

  • Rectoabdominally in males
  • Vaginoabdominally in females

     6. New tests-

  • Detection of antigens such as nuclear matrix proteins (NMP22) or mini chromosome maintence (MCM) in urine
  • Detect new or recurrent tumours

  

TREATMENT-

  1. Stage Tis, Ta, T1
  • Transurethral resection of tumour (Ta)
  • Chemotherapy- thiotepa (MC- BCG)/ adriamycin/ mitomycin
  • BCG or interferon immunotherapy (Tis)
  • T1- TUR + BCG + chemotherapy

    2. T2- T4 lesion

  • Radical cystectomy followed by chemotherapy
  • Neoadjuvant chemotherapy followed by Radical cystectomy

    3. Any T, N1, M0 or any T, N0, M1

  • Systemic chemotherapy

    4. Small lesions

  • Partial cystectomy

Exam Important

ETIOLOGY-

  1. Transitional cell carcinoma
  • Cigratte smoking (MC)
  • Chemical carcinogens- naphthylamine benzidine, aniline, acrolein, hydrocarbons (BHAAM)
  • Schistosomiasis
  • Drugs- phenacetin, chlornaphazine, cyclophosphamide, analgesic
  • Pelvic irradiation
  • Occupation- rubber, leather etc

    2. Squamous cell carcinoma

  • Schistosomiasis
  • Chronic UTI
  • Bladder diverticula

    3. Adenocarcinoma (5%)

  • Urahal remnants
  • Ectopia vesicae
  • Occurs in intestinal urinary conduits, augmentation, pouches and ureterosigmoidotomies

FEATURES-

  1. Transitional Cell carcinoma
  • MC type of bladder tumour
  • MC appears as papillary or exophytic lesions
  • Carcinoma in situ or flat urotheal carcinoma
  • Pagetoid spread
  • Sites- lateral wall (MC), trigone

     2. Squamous Cell carcinoma-

  • Arise from lateral bladder wall and dome
  • Nodular and invasive

     3. Adenocarcinoma

  • 3 types- primary vesical, urchal, metastatic
  • Primary adenocarcinoma arise along the floor
  • Adenocarcinoma arising from urachus occurs at the dome.

 

PATHOLOGY-

  • MC type grossly in Papillary
  • MC type histologically Transitional cell carcinoma
INVESTIGATIONS-

  1. Cystoscopy (gold standard investigations)-
  • Cystoscopy and transurethral resection (TUR) is for diagnosis
  • Detecting cancer in symptomatic patient and assessing response to treatment
  • Most useful for early diagnosis of recurrence in TCC

     2. IVP-

  • Filling defect in bladder, dilatation of ureter

     3. Ultrasound-

  • It is useful investigation which can detect a bladder carcinoma
  • Can detect liver metastases

     4. CT scan is IOC for staging

     5. Bimanual palpation-

  • Rectoabdominally in males
  • Vaginoabdominally in females

     6. New tests-

  • Detection of antigens such as nuclear matrix proteins (NMP22) or mini chromosome maintence (MCM) in urine
  • Detect new or recurrent tumours

 

TREATMENT-

  1. Stage Tis, Ta, T1
  • Transurethral resection of tumour (Ta)
  • Chemotherapy- thiotepa (MC- BCG)/ adriamycin/ mitomycin
  • BCG or interferon immunotherapy (Tis)
  • T1- TUR + BCG + chemotherapy

    2. T2- T4 lesion

  • Radical cystectomy followed by chemotherapy
  • Neoadjuvant chemotherapy followed by Radical cystectomy

    3. Any T, N1, M0 or any T, N0, M1

  • Systemic chemotherapy

    4. Small lesions

  • Partial cystectomy

 

Don’t Forget to Solve all the previous Year Question asked on CARCINOMA OF URINARY BLADDER
Click Here to Start Quiz

Module Below Start Quiz

Leave a Comment

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support ❌